Where do Rhode Island med spa and injectable regulations come from?

Rhode Island med spas and injectors are governed by a mix of state and federal authorities — the Rhode Island legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for Rhode Island and flags what changed in plain language.

Does the FDA's GLP-1 compounding guidance apply in Rhode Island?

Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Rhode Island. We track those federal changes alongside any Rhode Island-specific rules so you see the full picture for your practice.

How do I keep up with Rhode Island regulatory changes?

Med Spa Radar sends a free weekly Brief on what changed across Rhode Island, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.

Rhode Island med spa & injectable regulations

What’s changing for med spas and injectors in Rhode Island — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Rhode Island. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.

Opening a med spa? We have not verified Rhode Island’s rules against the statute yet, so start with what opening a med spa requires →

Latest Rhode Island changes

No new Rhode Island changes in the last 13 months. We scan the Rhode Island legislature daily and nothing med-spa-relevant has moved since Jun 30, 2025. A quiet state is good news — the record below still applies, and the federal changes further down apply to every Rhode Island practice today.

CRITICALLegiScanJun 30, 2025
RI H5351: Mandates cosmetic medical procedures be performed by a physician, PA, APRN, or delegated to a qualified non-physician, non-PA or non-APRN under the supervision of a physician, physician assistant, or advanced practice registered nurse.
Major changes in who can perform cosmetic procedures in RI med spas.
MONITORLegiScanMar 22, 2024
RI S2870: Provides that the performance of cosmetic medical services is the practice of medicine and surgery.
New RI bill could redefine cosmetic medical services regulation.

Federal changes that apply in Rhode Island

FDA and Federal Register actions are nationwide — they govern Rhode Island practices too.

CAUTIONFEDERALFederal RegisterJul 30, 2026
FDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2027
New FDA fees for outsourcing facilities will impact med spas using compounds.
CRITICALFEDERALFDA Warning LetterJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
FDA warns Spa De Soleil over drug compounding practices.
MONITORFEDERALFederal RegisterJun 26, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period
FDA extends comment period on GLP-1 compounding decisions.
CRITICALFEDERALFDA Warning LetterJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA Warning Letter issued to ketaminelab.org for drugs.
CRITICALFEDERALFTC EnforcementJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
CAUTIONFEDERALFDA Drug ShortagesJun 11, 2026
FDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
Liraglutide is still on the FDA shortage list for compounding.

See the full regulatory feed →

What we monitor in Rhode Island

Rhode Island legislature — bills on injectables, GLP-1s & scope of practice
Rhode Island Board of Nursing — injector scope & delegation
Rhode Island Medical Board — physician supervision & ownership rules
Rhode Island Board of Pharmacy — compounding & 503A/503B
U.S. FDA — enforcement, warning letters, recalls, shortages
Federal Register — new rules on compounding & aesthetics

Rhode Island med spa compliance — FAQ

Where do Rhode Island med spa and injectable regulations come from?: Rhode Island med spas and injectors are governed by a mix of state and federal authorities — the Rhode Island legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for Rhode Island and flags what changed in plain language.
Does the FDA's GLP-1 compounding guidance apply in Rhode Island?: Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Rhode Island. We track those federal changes alongside any Rhode Island-specific rules so you see the full picture for your practice.
How do I keep up with Rhode Island regulatory changes?: Med Spa Radar sends a free weekly Brief on what changed across Rhode Island, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.

Get Rhode Island changes as they publish

We scan the Rhode Island legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.

Free · unsubscribe in one click · we never sell your address

← All states · Regulatory monitoring, not legal advice.